|
33
|
133
|
7fw1A |
Crystal structure of human fabp4 in complex with 2-cyclopentyl-4-(4-fluorophenyl)-6-[1-(methoxymethyl)cyclopentyl]-3-methyl-5-(1h-tetrazol-5-yl)pyridine |
|
30
|
133
|
7g1gA |
Crystal structure of human fabp4 in complex with 2-(2-hydroxy-3,5,5,8,8-pentamethyl-3,4,4a,6,7,8a-hexahydro-1h-naphthalen-2-yl)acetic acid |
|
31
|
133
|
7fwyA |
Crystal structure of human fabp4 in complex with 2-[(3-chloro-5,6-dihydrobenzo[b][1]benzothiepin-6-yl)sulfanyl]acetic acid |
|
33
|
134
|
7g1qA |
Crystal structure of human fabp5 in complex with (1s,2r)-2-[(5-carbamoyl-3-ethoxycarbonyl-4-methyl-2-thienyl)carbamoyl]cyclohexanecarboxylic acid |
|
31
|
133
|
7fwkA |
Crystal structure of human fabp4 in complex with 1-[(2-chlorophenyl)methyl]pyrrole-2-carboxamide |
|
31
|
134
|
7fvvA |
Crystal structure of human fabp4 in complex with (1s,2r)-2-[(5-carbamoyl-3-ethoxycarbonyl-4-methyl-2-thienyl)carbamoyl]cyclohexanecarboxylic acid |
|
31
|
133
|
7fvwA |
Crystal structure of human fabp4 in complex with 2-[2-(3-chlorophenyl)ethyl]-1,3-thiazole-4-carboxylic acid |
|
33
|
133
|
7fznA |
Crystal structure of human fabp4 in complex with (1s,2s,5r)-3-(2-thiophen-3-ylacetyl)-3-azabicyclo[3.1.0]hexane-2-carboxylic acid |
|
32
|
133
|
7fzcA |
Crystal structure of human fabp4 in complex with 5-[(2-chlorophenoxy)methyl]-4-propan-2-yl-1,2,4-triazole-3-thiol |
|
32
|
134
|
7fzbA |
Crystal structure of human fabp4 in complex with 2-[5-methyl-2-(1-methylcyclohexyl)-1,3-oxazol-4-yl]acetic acid |
|
31
|
133
|
7fyeA |
Crystal structure of human fabp4 in complex with 1-[(4-chlorophenyl)methyl]-4-hydroxypyridin-2-one |
|
31
|
135
|
7fybA |
Crystal structure of human fabp4 in complex with rac-(1r,2s,4r)-2-[(3-chlorobenzoyl)amino]-4-phenoxycyclohexane-1-carboxylic acid |
|
33
|
134
|
7fxxA |
Crystal structure of human fabp4 binding site mutated to that of fabp3 in complex with 6-cyclopentyl-n,5-dimethyl-4-phenyl-n-propan-2-yl-3-(1h-tetrazol-5-yl)pyridin-2-amine |
|
29
|
133
|
7fwcA |
Crystal structure of human fabp4 in complex with 5-(4-chlorophenyl)-2-(hydroxymethylene)cyclohexane-1,3-dione |
|
35
|
134
|
7fvxA |
Crystal structure of human fabp4 in complex with 4-(1-methyl-2-phenylindol-3-yl)cyclohexane-1-carboxylic acid |
|
32
|
135
|
7fxvA |
Crystal structure of human fabp4 in complex with 6-[(4-methoxyphenyl)methyl]-2h-1,2,4-triazine-3,5-dithione |
|
34
|
127
|
7g00A |
Crystal structure of human fabp1 in complex with 2-[[3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl]cyclopentene-1-carboxylic acid |
|
28
|
134
|
7fy1A |
Crystal structure of apo human fabp9 |
|
32
|
133
|
7fxfA |
Crystal structure of human fabp4 in complex with 2-[(2-chlorophenoxy)methyl]-1,3-thiazole-4-carboxylic acid |
|
30
|
133
|
7fy5A |
Crystal structure of human fabp4 in complex with 2,5,5-trimethyl-6,7,8,9-tetrahydrobenzo[7]annulene-3-carboxylic acid |
|
33
|
134
|
7fzsA |
Crystal structure of human fabp4 in complex with 6-chloro-4-[(2-chlorophenyl)methyl]-2-methylquinoline-3-carboxylic acid |
|
31
|
134
|
7fx5A |
Crystal structure of human fabp4 in complex with 5-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-6,6-difluoro-5,7-dihydro-4h-1-benzothiophen-2-yl]carbamoyl]-3,6-dihydro-2h-pyran-4-carboxylic acid |
|
34
|
133
|
7fwoA |
Crystal structure of human fabp4 in complex with 2-cyclohexyl-6-hydroxy-1-benzofuran-3-one |
|
33
|
135
|
7fwqA |
Crystal structure of human fabp4 binding site mutated to that of fabp3 in complex with 6-chloro-4-(2-chlorophenoxy)-2-methylquinoline-3-carboxylic acid |
|
29
|
134
|
7g0uA |
Crystal structure of human fabp4 in complex with 5-[(3-chlorophenyl)methyl]-6-hydroxy-1-methyl-4-morpholin-4-ylpyrimidin-2-one |
|
32
|
134
|
7g0rA |
Crystal structure of human fabp4 in complex with 4-methoxy-1,2-benzoxazol-3-amine |
|
28
|
130
|
7fwxA |
Crystal structure of human fabp4 binding site mutated to that of fabp5 |
|
31
|
134
|
7g0lA |
Crystal structure of human fabp4 in complex with 3-[(4-methyl-3-phenoxyphenyl)methyl]-1h-pyrazol-5-ol |
|
32
|
134
|
7fzwA |
Crystal structure of human fabp4 in complex with 2-[[5-bromo-2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid |
|
31
|
134
|
7fx6A |
Crystal structure of human fabp4 in complex with n,n-diethyl-4-pyridin-4-yl-3-(1h-tetrazol-5-yl)-6,7,8,9-tetrahydro-5h-cyclohepta[b]pyridin-2-amine |
|
31
|
133
|
7fzlA |
Crystal structure of human fabp4 in complex with 3-(3-chlorophenyl)-4-prop-2-enyl-1h-1,2,4-triazole-5-thione |
|
32
|
134
|
7g07A |
Crystal structure of human fabp4 in complex with 4-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl]-3,6-dihydro-2h-pyran-5-carboxylic acid |
|
33
|
133
|
7fx8A |
Crystal structure of human fabp4 in complex with 4-(2-methylpropyl)-2-phenyl-3-(1h-tetrazol-5-yl)-6,7,8,9-tetrahydro-5h-cyclohepta[b]pyridine |
|
31
|
133
|
7fzdA |
Crystal structure of human fabp4 in complex with 3-(4-chlorophenyl)-4,5,6,6a-tetrahydro-3ah-cyclopenta[d][1,2]oxazole-5-carboxylic acid |
|
34
|
134
|
7fwuA |
Crystal structure of human fabp4 in complex with 2-(fluoren-9-ylidenemethyl)-4-hydroxy-2,3-dihydropyran-6-one |
|
31
|
132
|
7fzgA |
Crystal structure of apo mouse fabp4, c-centered orthorhombic form |
|
32
|
134
|
7fwwA |
Crystal structure of human fabp4 in complex with (3-bromophenyl)-[(2z)-2-phenylimino-1,3-thiazepan-3-yl]methanone |
|
31
|
129
|
7fyaA |
Crystal structure of apo human fabp1 - orthorhombic form |
|
30
|
133
|
7fypA |
Crystal structure of human fabp4 in complex with (1s,2s)-2-[(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl]oxycarbonylcyclopropane-1-carboxylic acid |
|
33
|
134
|
7fxjA |
Crystal structure of human fabp4 in complex with 1-[(4-chlorophenyl)methyl]-3,4-dihydroxy-2h-pyrrol-5-one |
|
31
|
135
|
7fyjA |
Crystal structure of human fabp4 in complex with 5-[(3-chloro-2-methylphenoxy)methyl]-2-phenyl-4h-[1,2,4]triazolo[1,5-a]pyrimidin-7-one |
|
32
|
133
|
7g14A |
Crystal structure of human fabp4 in complex with 6-cyclopentyl-n,5-dimethyl-4-phenyl-n-propan-2-yl-3-(1h-tetrazol-5-yl)pyridin-2-amine |
|
32
|
133
|
7g1kA |
Crystal structure of human fabp4 in complex with 4-(4-fluorophenyl)sulfanyl-6-methyl-2-phenylpyrimidine-5-carboxylic acid |
|
31
|
133
|
7g1eA |
Crystal structure of human fabp4 in complex with 3-[(2-phenylphenoxy)methyl]benzoic acid |
|
32
|
130
|
7g12A |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with n-methyl-6-(3-methylthiophen-2-yl)-4-phenyl-n-propan-2-yl-3-(1h-tetrazol-5-yl)pyridin-2-amine |
|
32
|
135
|
7fw4A |
Crystal structure of human fabp4 soaked with glycerol |
|
33
|
134
|
7g10A |
Crystal structure of human fabp4 binding site mutated to that of fabp3 in complex with 1-[(4-chloro-2-phenoxyphenyl)methyl]-4-hydroxypyridin-2-one |
|
32
|
133
|
7fw3A |
Crystal structure of human fabp4 in complex with 7-(4-chlorophenyl)-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid |
|
32
|
133
|
7fw0A |
Crystal structure of human fabp4 in complex with 3-methyl-2-(2,4,5-trichlorophenyl)sulfanylbutanoic acid |
|
30
|
134
|
7g1uA |
Crystal structure of human fabp4 in complex with 2-[[5-chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid |
